Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nassim H. Nabbout"'
Autor:
Khalil Choucair, Seth J. Page, Bassam I. Mattar, Christopher S. Dakhil, Nassim H. Nabbout, Jeremy M. Deutsch, Quoc V. Truong, Phu V. Truong, Dennis F. Moore, Michael W. Cannon, K. James Kallail, Joseph A. Moore, Shaker R. Dakhil, Radwan Diab, Syed Kamran, Pavan S. Reddy
Publikováno v:
Clinical breast cancer.
RNA-based genomic risk assessment estimates chemotherapy benefit in patients with hormone-receptor positive (HR+)/Human Epidermal Growth Factor 2-negative (ERBB2-) breast cancer (BC). It is virtually used in all patients with early HR+/ERBB2- BC rega
Autor:
Khalil Choucair, Bassam Ibrahim Mattar, Quoc Van Truong, Travis Koeneke, Phu Van Truong, Christopher Dakhil, Michael W Cannon, Seth Joel Page, Jeremy Michael Deutsch, Eric Carlson, Dennis Frederic Moore, Nassim H Nabbout, K James Kallail, Shaker R Dakhil, Pavan S Reddy
Publikováno v:
The oncologist. 27(3)
Background Liquid biopsy testing offers a significant potential in selecting signal-matched therapies for advanced solid malignancies. The feasibility of liquid biopsy testing in a community-based oncology practice, and its actual impact on selecting
Autor:
Khalil Choucair, Seth Joel Page, Bassam Ibrahim Mattar, Christopher Dakhil, Nassim H. Nabbout, Jeremy Michael Deutsch, Quoc Van Truong, Phu Van Truong, Dennis Frederic Moore, Michael W. Cannon, K. James Kallail, Joseph A Moore, Shaker R. Dakhil, Radwan Diab, Syed Kamran, Pavan S. Reddy
Publikováno v:
Journal of Clinical Oncology. 40:546-546
546 Background: RNA-based genomic assessment of recurrence risk is used to estimate chemotherapy benefit in patients with hormone-receptor positive (HR+)/Human Epidermal Growth Factor 2-negative ( ERBB2-) breast cancer (BC). While originally validate
Autor:
Seth Joel Page, Eric A. Carlson, Quoc Truong, Michael W. Cannon, Shaker R. Dakhil, Jeremy M Deutsch, Phu Van Truong, Christopher Dakhil, Travis Lee Koeneke, K James Kallail, Pavan S. Reddy, Bassam I. Mattar, Khalil Choucair, Dennis F. Moore, Nassim H. Nabbout
Publikováno v:
Journal of Clinical Oncology. 39:3027-3027
3027 Background: Liquid biopsy is a promising, rapid and minimally invasive genetic test examining circulating tumor DNA. It offers a significant potential in selecting signal-matched therapeutic options. Methods: A retrospective chart review was con
Autor:
Betsy LaPlant, Dennis F. Moore, Nassim H. Nabbout, Axel Grothey, Kendrith M. Rowland, Thomas E. Witzig, Daniel A. Nikcevich, Patrick B. Johnston, Levi Pederson, Paul J. Kurtin
Publikováno v:
American Journal of Hematology. 92:1004-1010
Patients with relapsed aggressive non-Hodgkin lymphoma (NHL) are often treated with platinum-based chemoimmunotherapy regimens in preparation for autologous stem cell transplant. We sought to reduce toxicity and maintain efficacy by using oxaliplatin
Autor:
Mary F. Mulcahy, Joseph A. Sparano, Joel M. Palefsky, Karin I. Armstrong, Adedayo A. Onitilo, Richard Whittington, Edith P. Mitchell, Madhur Garg, Al B. Benson, Bassel F. El-Rayes, Shalom Kalnicki, Nassim H. Nabbout, Fengmin Zhao, Daniel J. Moriarty, Thomas J. Fitzgerald
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 35, iss 7
Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional failure (LRF) rates after sphincter-preserving definitive chemoradiation (CRT) and is typically associated with anogenital human papilloma virus infection
Autor:
Christopher Dakhil, Quoc Truong, Pavan S. Reddy, Khalil Choucair, Dennis F. Moore, Jeremy M Deutsch, Eric A. Carlson, Travis Lee Koeneke, K James Kallail, Shaker R. Dakhil, Michael W. Cannon, Nassim H. Nabbout, Seth Joel Page, Phu Van Truong, Bassam I. Mattar
Publikováno v:
Journal of Clinical Oncology. 38:3527-3527
3527 Background: Liquid biopsy is a promising and minimally invasive genetic test examining plasma circulating tumor DNA. Coupled with the rapidly developing next-generation sequencing (NGS) technologies, it holds the potential for implementation in
Autor:
Bassam I. Mattar, Seth Joel Page, Pavan S. Reddy, Phu Van Truong, Jeremy M Deutsch, Chris Dakhil, Derek Young, Nassim H. Nabbout, Michael W. Cannon, Shaker R. Dakhil, Patricia Bluml, Quoc Truong
Publikováno v:
Journal of Clinical Oncology. 36:e19505-e19505
e19505Background: Filgrastim-sndz was the first biosimilar granulocyte colony stimulating factor to be approved by the FDA for the same indications, including peripheral blood stem cell mobilizatio...
Autor:
Nassim H. Nabbout
Publikováno v:
Journal of Clinical Oncology. 35:e18531-e18531
e18531 Neutropenic Fever Prophylaxis During Induction Therapy for Acute Myeloid Leukemia Nassim Nabbout, MD, Salam Kadhem, MD, Rawaa Ebrahem, MD, Rossa Khalaf, MD, Baharat Malhotra, MD, K. James Kallail, PhD Background: Neutropenic fever is an oncolo
Autor:
Bassam I. Mattar, Seth Joel Page, Ahmad K. Rahal, Quoc Truong, Jeremy M Deutsch, Phu Van Truong, K James Kallail, Nassim H. Nabbout, Dennis F. Moore, Shaker R. Dakhil, Pavan S. Reddy, Christopher Dakhil, Michael W. Cannon
Publikováno v:
Journal of Clinical Oncology. 34:e23145-e23145
e23145Background: The advent of next-generation sequencing (NGS) for cancer holds promise for targeted therapy, but the practical issues surrounding integration of this testing into the community o...